- Report
- May 2023
- 116 Pages
Global
From €4006EUR$4,500USD£3,500GBP
- Report
- June 2025
- 250 Pages
Japan
From €2483EUR$2,789USD£2,169GBP
- Report
- June 2024
- 124 Pages
Global
From €4447EUR$4,995USD£3,885GBP
- Report
- December 2023
- 299 Pages
Global
€4447EUR$4,995USD£3,885GBP
- Report
- June 2023
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Database
- July 2023
Global
From €320EUR$360USD£280GBP
- Report
- April 2024
- 132 Pages
Global
From €846EUR$950USD£739GBP
The Electronic Clinical Outcome Assessment (eCOA) market is a subset of the e-Healthcare industry. It is focused on the collection of patient-reported outcomes (PROs) and clinical data from clinical trials and other healthcare settings. eCOA solutions are used to measure patient-reported outcomes such as quality of life, symptom severity, and treatment satisfaction. These solutions are designed to improve the accuracy and reliability of data collection, reduce the burden on healthcare providers, and improve patient engagement.
eCOA solutions are used in a variety of healthcare settings, including clinical trials, post-marketing surveillance, and patient-reported outcomes research. They are also used to support patient-centered care, such as patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs).
Some companies in the eCOA market include eClinical Solutions, Medidata Solutions, Oracle Health Sciences, and Parexel. Show Less Read more